Human Immunodeficiency Virus Type 1-Mediated Syncytium Formation Is Compatible with Adenovirus Replication and Facilitates Efficient Dispersion of Viral Gene Products andDe Novo-Synthesized Virus Particles-Reference-Cited by-同舟云学术

Human Immunodeficiency Virus Type 1-Mediated Syncytium Formation Is Compatible with Adenovirus Replication and Facilitates Efficient Dispersion of Viral Gene Products andDe Novo-Synthesized Virus Particles

Published:2001-12-10 Issue:18 Volume:12 Page:2155-2165
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Li Hui¹,Haviv Yosef S.¹,Derdeyn Cynthia A.²,Lam John¹,Coolidge Candace³,Hunter Eric²,Curiel David T.¹,Blackwell Jerry L.¹

Affiliation:

1. Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, and Gene Therapy Center, University of Alabama at Birmingham, Birmingham, AL 35294

2. Department of Microbiology and Center for AIDS Research, University of Alabama at Birmingham, Birmingham, AL 35294

3. Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430340152710504

Reference61 articles.

1. Replicative adenoviruses for cancer therapy

2. Envelope Gene of the Human Endogenous Retrovirus HERV-W Encodes a Functional Retrovirus Envelope

3. An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

4. Mutations within the env gene of Mason-Pfizer monkey virus: effects on protein transport and SU-TM association

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The genome position of a therapeutic transgene strongly influences the level of expression in an armed oncolytic human adenovirus vector;Virology;2021-09

2. Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment;Molecular Therapy;2021-05

3. Strategies for enhancing intratumoral spread of oncolytic adenoviruses;Pharmacology & Therapeutics;2020-09

4. Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic;Cancer Gene Therapy;2020-07-01

5. An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate In Vivo;Molecular Therapy - Oncolytics;2019-09